Cocaine Should NOT Be Used for Topical Anesthesia
Cocaine is not recommended for topical anesthesia in modern clinical practice due to significant cardiovascular toxicity risks, and should be replaced with safer alternatives such as lidocaine combined with phenylephrine. 1
Why Cocaine Is Contraindicated
The 2020 Difficult Airway Society guidelines explicitly state that cocaine for topicalization and vasoconstriction can be associated with toxic cardiovascular complications 1. Most critically, the guideline provides a Grade A recommendation (the highest level) that cocaine in airway topicalization is not advised, and phenylephrine in combination with lidocaine is more appropriate 1.
The evidence demonstrates that cocaine's analgesic efficacy during nasotracheal tube insertion is no better than co-phenylcaine (2.5 ml lidocaine 5%/phenylephrine 0.5%), yet carries substantially higher cardiovascular risks 1.
Historical Context (For Reference Only)
While older literature from the 1970s-1990s suggested cocaine doses for ENT procedures, these recommendations are outdated and superseded by current safety guidelines:
- Historical otolaryngology practice used 200-300 mg for adult nasal procedures 2
- Some practitioners used >200 mg without apparent reactions 3
- Pediatric TAC (tetracaine-adrenaline-cocaine) formulations used 2-3 ml of "half-strength" solutions 4, 5
However, these historical doses are no longer clinically relevant given current evidence-based recommendations against cocaine use.
Critical Safety Concerns
Cardiovascular Toxicity
- Cocaine causes toxic cardiovascular complications even at therapeutic doses 1
- Deaths have occurred from topical application, including two pediatric fatalities from TAC application to mucous membranes 5
- Cocaine sensitizes patients to exogenous epinephrine, potentially amplifying toxicity 6
Unpredictable Toxicity
- Reactions can occur with doses as low as 10 mg 3
- Toxicity is not simply dose-dependent 3
- Mucous membrane application dramatically increases absorption and risk 5
Recommended Alternative
Use lidocaine (maximum 9 mg/kg lean body weight) combined with phenylephrine for topical anesthesia requiring vasoconstriction 1. This combination provides:
- Equivalent anesthetic efficacy
- Effective vasoconstriction
- Superior safety profile
- Lower cardiovascular risk
Lidocaine Dosing Parameters
- Maximum dose: 9 mg/kg lean body weight (not a target, but an absolute ceiling) 1
- Account for all routes of administration (topical, regional, infiltration) 1
- Most procedures require far less than the maximum dose 1
Common Pitfall to Avoid
Do not assume that because cocaine was historically used safely in ENT practice that it remains appropriate today. The 2020 Grade A guideline recommendation explicitly advises against its use based on superior alternatives and unacceptable cardiovascular risk 1.